Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, United Kingdom.
JAMA Neurol. 2022 Sep 1;79(9):949-951. doi: 10.1001/jamaneurol.2022.1824.
This case series investigates the association of a segmental, facial, antibody-associated brainstem sensory syndrome with the immune checkpoint inhibitor pembrolizumab.
本病例系列研究了节段性、面部、抗体相关的脑干感觉综合征与免疫检查点抑制剂 pembrolizumab 的关联。